Induced CD4 +Foxp3 + regulatory T cells in immune tolerance

Annual Review of Immunology

Volumn 30, Issue , 2012, Pages 733-758

  Bilate, Angelina M ^a   Lafaille, Juan J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Foxp3; Induced Treg cells; Inflammation; Mucosal tolerance

Indexed keywords

GAMMA INTERFERON; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 23; RAPAMYCIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ENCEPHALOMYELITIS; ALLOTRANSPLANTATION; ANTIGEN PRESENTING CELL; ARTHRITIS; ASTHMA; CD4+ T LYMPHOCYTE; CELL DEATH; CELL LINE; CELL METABOLISM; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL THERAPY; CELL TRANSFORMATION; CLINICAL TRIAL (TOPIC); COLITIS; COLORECTAL CANCER; DENDRITIC CELL; DIABETES MELLITUS; DISEASE MODEL; DISEASE SEVERITY; EFFECTOR CELL; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATION; INTESTINE FLORA; INTESTINE LYMPHATIC TISSUE; LAMINA PROPRIA; LEISHMANIA MAJOR; LIVER INJURY; LYMPHOCYTE DIFFERENTIATION; LYMPHOPROLIFERATIVE DISEASE; NATURAL KILLER CELL; NONHUMAN; PARASITOSIS; PEYER PATCH; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; VIRAL CLEARANCE; VIRUS INFECTION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD4; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; LYMPHOID TISSUE; T-LYMPHOCYTES, REGULATORY;

EID: 84859390119     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-020711-075043     Document Type: Review

References (163)

1. Hori S, Nomura T, Sakaguchi S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057-61
2. + regulatory T cells. Nat. Immunol. 4:330-36
3. + T regulatory cells. Nat. Immunol. 4:337-42
4. - T cells. J. Clin. Investig. 112:1437-43
5. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, et al. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27:20-21
6. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, et al. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27:18-20
7. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, et al. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27:68-73
8. Apostolou I, von Boehmer H. 2004. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199:1401-8
9. + regulatory T cells by peripheral expansion. J. Immunol. 173:7259-68
10. + regulatory T cells in the periphery ofTcell receptor transgenicmice tolerized to transplants. J. Immunol. 172:6003-10
11. MucidaD, KutchukhidzeN, Erazo A, Russo M, Lafaille JJ, Curotto de Lafaille MA. 2005. Oral tolerance in the absence of naturally occurring Tregs. J. Clin. Investig. 115:1923-33
12. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von BoehmerH. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6:1219-27
13. + regulatory T cells in Heligmosomoides polygyrus infection. Eur. J. Immunol. 37:1874-86
14. + regulatory T cell-dependent and-independent control of allergic inflammation. Immunity 29:114-26
15. + regulatory T cells: more of the same or a division of labor? Immunity 30:626-35
16. Haribhai D, Lin W, Edwards B, Ziegelbauer J, Salzman NH, et al. 2009. A central role for induced regulatory T cells in tolerance induction in experimental colitis. J. Immunol. 182:3461-68
17. - precursors. J. Immunol. 169:4183-89
18. + regulatory T cells by TGF-βinduction of transcription factor Foxp3. J. Exp. Med. 198:1875-86
19. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172:5149-53
20. + natural regulatory T cells revealed by DNA microarray analysis. Int. Immunol. 18:1197-209
21. Hill JA, Feuerer M, Tash K, Haxhinasto S, Perez J, et al. 2007. Foxp3 transcription-factor-dependent and-independent regulation of the regulatory T cell transcriptional signature. Immunity 27:786-800
22. FeuererM, Hill JA, Kretschmer K, von Boehmer H, Mathis D, Benoist C. 2010. Genomic definition of multiple ex vivo regulatory T cell subphenotypes. Proc. Natl. Acad. Sci. USA 107:5919-24
23. Haribhai D, Williams JB, Jia S, Nickerson D, Schmitt EG, et al. 2011. A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity 35:109-22
24. + regulatory T cells. J. Immunol. 170:3939-43
25. Bilate AB, Lafaille JJ. 2011. It takes two to tango. Immunity 35:6-8
26. + regulatory T cells rescue scurfy mice. Eur. J. Immunol. 38:1814-21
27. Huter EN, Stummvoll GH, DiPaolo RJ, Glass DD, Shevach EM. 2008. Cutting edge: antigen-specific TGFβ-induced regulatoryTcells suppressTh17-mediated autoimmune disease. J. Immunol. 181:8209-13
28. D'Alise AM, Ergun A, Hill JA, Mathis D, Benoist C. 2011. A cluster of coregulated genes determines TGF-β-induced regulatory T-cell (Treg) dysfunction in NOD mice. Proc. Natl. Acad. Sci. USA 108:8737-42
29. + T regulatory cells. J. Immunol. 184:3433-41
30. + T regulatory cells. " J. Immunol. 185:7129-30
31. Akimova T, Beier UH, Wang L, Levine MH, Hancock WW. 2011. Helios expression is a marker of T cell activation and proliferation. PLoS ONE 6:e24226
32. Sarris M, Andersen KG, Randow F, Mayr L, Betz AG. 2008. Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity 28:402-13
33. Bruder D, Probst-KepperM, Westendorf AM, Geffers R, Beissert S, et al. 2004. Neuropilin-1: a surface marker of regulatory T cells. Eur. J. Immunol. 34:623-30
34. Neufeld G, Cohen T, ShragaN, Lange T, Kessler O, Herzog Y. 2002. The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc. Med. 12:13-19
35. Glinka Y, Stoilova S, Mohammed N, Prud'homme GJ. 2011. Neuropilin-1 exerts co-receptor function for TGF-β-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-β. Carcinogenesis 32:613-21
36. Corbel C, Lemarchandel V, Thomas-Vaslin V, Pelus AS, Agboton C, Romeo PH. 2007. Neuropilin 1 and CD25 co-regulation during early murine thymic differentiation. Dev. Comp. Immunol. 31:1082-94
37. Solomon BD, Mueller C, ChaeWJ, Alabanza LM, Bynoe MS. 2011. Neuropilin-1 attenuates autoreactivity in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 108:2040-45
38. Wilke CM, Wu K, Zhao E, Wang G, Zou W. 2010. Prognostic significance of regulatory T cells in tumor. Int. J. Cancer 127:748-58
39. Nishikawa H, Sakaguchi S. 2010. Regulatory T cells in tumor immunity. Int. J. Cancer 127:759-67
40. Brunstein CG, Miller JS, Cao Q, McKenna DH, Hippen KL, et al. 2011. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 117:1061-70
41. Quezada SA, Peggs KS, Simpson TR, Allison JP. 2011. Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication. Immunol. Rev. 241:104-18
42. Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E. 1999. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody. Cancer Res. 59:3128-33
43. + T cells: a common basis between tumor immunity and autoimmunity. J. Immunol. 163:5211-18
44. Turk MJ, Guevara-Patino JA, Rizzuto GA, Engelhorn ME, Sakaguchi S, Houghton AN. 2004. Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J. Exp. Med. 200:771-82
45. + regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer Immunol. Immunother. 60:909-18
46. - lymphocytes is thymus and proliferation independent. Cancer Res. 66:4488-95
47. + T regulatory cells: role of tumor-derived TGF-β. J. Immunol. 178:2883-92
48. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, et al. 2004. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10:942-49
49. Hindley JP, Ferreira C, Jones E, Lauder SN, Ladell K, et al. 2011. Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors. Cancer Res. 71:736-46
50. Zhou G, Levitsky HI. 2007. Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance. J. Immunol. 178:2155-62
51. + regulatory T cell proliferation. J. Exp. Med. 202:919-29
52. Montane J, Bischoff L, Soukhatcheva G, Dai DL, Hardenberg G, et al. 2011. Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets. J. Clin. Investig. 121:3024-28
53. + T regulatory cells in renal cell carcinoma co-express Helios, indicating they could be derived from natural but not induced Tregs. Clin. Immunol. 140:218-22
54. + T regulatory cells. J. Immunol. 176:3301-5
55. + T regulatory cells. " J. Immunol. 177:2036-38
56. + regulatory T cells responsible for protection against diabetes. Proc. Natl. Acad. Sci. USA 101:4572-77
57. + T cells. J. Immunol. 173:6526-31
58. Richman LK, Chiller JM, BrownWR, Hanson DG, Vaz NM. 1978. Enterically induced immunologic tolerance. I. Induction of suppressor T lymphocytes by intragastric administration of soluble proteins. J. Immunol. 121:2429-34
59. ChaseMW. 1946. Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc. Soc. Exp. Biol. Med. 61:257-59
60. Hanson DG, Vaz NM, Maia LC, Hornbrook MM, Lynch JM, Roy CA. 1977. Inhibition of specific immune responses by feeding protein antigens. Int. Arch. Allergy Appl. Immunol. 55:526-32
61. Vaz NM, Maia LC, Hanson DG, Lynch JM. 1977. Inhibition of homocytotropic antibody responses in adult inbred mice by previous feeding of the specific antigen. J. Allergy Clin. Immunol. 60:110-15
62. Gutgemann I, Fahrer AM, Altman JD, Davis MM, Chien YH. 1998. Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity 8:667-73
63. Chen Y, Inobe J, Marks R, Gonnella P, Kuchroo VK, Weiner HL. 1995. Peripheral deletion of antigenreactive T cells in oral tolerance. Nature 376:177-80
64. Van Houten N, Blake SF. 1996. Direct measurement of anergy of antigen-specific T cells following oral tolerance induction. J. Immunol. 157:1337-41
65. McMenamin C, McKerseyM, Kuhnlein P, Hunig T, Holt PG. 1995. γδT cells down-regulate primary IgE responses in rats to inhaled soluble protein antigens. J. Immunol. 154:4390-94
66. AlpanO, BachelderE, IsilE, Arnheiter H, Matzinger P. 2004. 'Educated' dendritic cells act as messengers from memory to naive T helper cells. Nat. Immunol. 5:615-22
67. + regulatory T cells by oral antigen administration. J. Immunol. 167:4245-53
68. + mucosal regulatory T cells are induced in gut-draining lymphoid tissue within 48 h after oral antigen application. Eur. J. Immunol. 33:2801-10
69. Thorstenson KM, Khoruts A. 2001. Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 167:188-95
70. Lafaille JJ, Nagashima K, Katsuki M, Tonegawa S. 1994. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78:399-408
71. Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, Rudensky AY. 2010. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463:808-12
72. Guarner F, Malagelada JR. 2003. Gut flora in health and disease. Lancet 361:512-19
73. Round JL, Mazmanian SK. 2009. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9:313-23
74. Faria AM, Weiner HL. 2005. Oral tolerance. Immunol. Rev. 206:232-59
75. Gaboriau-Routhiau V, Rakotobe S, Lecuyer E, Mulder I, Lan A, et al. 2009. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31:677-89
76. Ivanov II, Frutos Rde L, Manel N, Yoshinaga K, Rifkin DB, et al. 2008. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4:337-49
77. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, et al. 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485-98
78. PrioultG, Nagler-AndersonC. 2005. Mucosal immunity and allergic responses: lack of regulation and/or lack of microbial stimulation? Immunol. Rev. 206:204-18
79. + T cells. Clin. Exp. Immunol. 153:127-35
80. Moreau MC, Gaboriau-Routhiau V. 1996. The absence of gut flora, the doses of antigen ingested and aging affect the long-term peripheral tolerance induced by ovalbumin feeding in mice. Res. Immunol. 147:49-59
81. Rask C, Evertsson S, Telemo E, Wold AE. 2005. A full flora, but not monocolonization by Escherichia coli or lactobacilli, supports tolerogenic processing of a fed antigen. Scand. J. Immunol. 61:529-35
82. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. 1997. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 159:1739-45
83. Walton KL, Galanko JA, Balfour Sartor R, Fisher NC. 2006. T cell-mediated oral tolerance is intact in germ-free mice. Clin. Exp. Immunol. 143:503-12
84. Ostman S, Rask C, Wold AE, Hultkrantz S, Telemo E. 2006. Impaired regulatory T cell function in germ-free mice. Eur. J. Immunol. 36:2336-46
85. Min B, Thornton A, Caucheteux SM, Younes SA, Oh K, et al. 2007. Gut flora antigens are not important in the maintenance of regulatory T cell heterogeneity and homeostasis. Eur. J. Immunol. 37:1916-23
86. Shroff KE, Cebra JJ. 1995. Development of mucosal humoral immune responses in germ-free (GF) mice. Adv. Exp. Med. Biol. 371A:441-46
87. Umesaki Y, Setoyama H, Matsumoto S, Okada Y. 1993. Expansion of αβ T-cell receptor-bearing intestinal intraepithelial lymphocytes aftermicrobial colonization in germ-free mice and its independence from thymus. Immunology 79:32-37
88. Suzuki H, Jeong KI, Itoh K, Doi K. 2002. Regional variations in the distributions of small intestinal intraepithelial lymphocytes in germ-free and specific pathogen-free mice. Exp. Mol. Pathol. 72:230-35
89. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, et al. 2011. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:337-41
90. + regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. USA 107:12204-9
91. Round JL, Lee SM, Li J, Tran G, Jabri B, et al. 2011. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332:974-77
92. Lathrop SK, Bloom SM, Rao SM, Nutsch K, Lio CW, et al. 2011. Peripheral education of the immune system by colonic commensal microbiota. Nature 478:250-54
93. Geuking MB, Cahenzli J, Lawson MA, Ng DC, Slack E, et al. 2011. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 34:794-806
94. Curotto de Lafaille MA, Muriglan S, Sunshine MJ, Lei Y, Kutchukhidze N, et al. 2001. Hyper immunoglobulin E response in mice with monoclonal populations of B and T lymphocytes. J. Exp. Med. 194:1349-59
95. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, et al. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-38
96. + Treg development and function during allergic airway inflammation in vivo. J. Clin. Investig. 115:313-25
97. Furtado GC, Marcondes MC, Latkowski JA, Tsai J, Wensky A, Lafaille JJ. 2008. Swift entry of myelinspecific T lymphocytes into the central nervous system in spontaneous autoimmune encephalomyelitis. J. Immunol. 181:4648-55
98. Nguyen LT, Jacobs J, Mathis D, Benoist C. 2007. Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum. 56:509-20
99. Korn T, Reddy J, GaoW, Bettelli E, Awasthi A, et al. 2007. Myelin-specific regulatoryTcells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13:423-31
100. + regulatory T cells upon peripheral proinflammatory immunization. J. Immunol. 185:3829-33
101. Wan YY, Flavell RA. 2005. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102:5126-31
102. Belkaid Y, Tarbell K. 2009. Regulatory T cells in the control of host-microorganism interactions. Annu. Rev. Immunol. 27:551-89
103. Gomez-EscobarN, GregoryWF, Maizels RM. 2000. Identification of tgh-2, a filarial nematode homolog of Caenorhabditis elegans daf-7 and human transforming growth factor β, expressed in microfilarial and adult stages of Brugia malayi. Infect. Immun. 68:6402-10
104. + regulatory T cells control Leishmania major persistence and immunity. Nature 420:502-7
105. Elliott DE, Setiawan T, Metwali A, Blum A, Urban JF Jr, Weinstock JV. 2004. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur. J. Immunol. 34:2690-98
106. + regulatory T cells in mice infected with the filarial parasite Brugia malayi. J. Immunol. 181:6456-66
107. Grainger JR, Smith KA, Hewitson JP, McSorley HJ, Harcus Y, et al. 2010. Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway. J. Exp. Med. 207:2331-41
108. + T cells during Listeria monocytogenes infection. J. Immunol. 182:3032-38
109. + CD25high regulatoryTcells suppressmemoryT-cell responses to H. pylori in infected individuals. Infect. Immun. 71:1755-62
110. Lund JM, Hsing L, Pham TT, Rudensky AY. 2008. Coordination of early protective immunity to viral infection by regulatory T cells. Science 320:1220-24
111. + CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection. J. Immunol. 185:2382-92
112. + regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J. Immunol. 177:739-47
113. + regulatory T cells in patients with hepatitis B virus infection. J. Virol. 79:3322-28
114. Barboza L, Salmen S, Goncalves L, Colmenares M, Peterson D, et al. 2007. Antigen-induced regulatory T cells in HBV chronically infected patients. Virology 368:41-49
115. +CD25high regulatory T cells during acute hepatitis C virus infection. J. Infect. Dis. 197:46-57
116. + T cells during persistent hepatitis C virus infection. J. Virol. 79:7852-59
117. + T cell lineage differentiation. Immunity 30:646-55
118. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22:329-41
119. + natural regulatory T cells are specific for microbial antigens. J. Exp. Med. 203:777-88
120. + Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31:772-86
121. Kamphorst AO, Guermonprez P, Dudziak D, Nussenzweig MC. 2010. Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes. J. Immunol. 185:3426-35
122. Darrasse-Jeze G, Deroubaix S, Mouquet H, Victora GD, Eisenreich T, et al. 2009. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med. 206:1853-62
123. + regulatory T cells from peripheral Foxp3 precursors. Blood 110:4293-302
124. + regulatory T cells by targeting of antigens to immature dendritic cells. Blood 101:4862-69
125. Belkaid Y, Oldenhove G. 2008. Tuning microenvironments: induction of regulatory T cells by dendritic cells. Immunity 29:362-71
126. + regulatory T cells. J. Immunol. 181:6923-33
127. + T-cell compartment by antigen targeting to DNGR-1/CLEC9A. Eur. J. Immunol. 40:1255-65
128. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, et al. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317:256-60
129. SunCM, Hall JA, Blank RB, Bouladoux N, Oukka M, et al. 2007. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204:1775-85
130. + regulatory T cells via a TGF-βand retinoic aciddependent mechanism. J. Exp. Med. 204:1757-64
131. Denning TL, Wang YC, Patel SR, Williams IR, Pulendran B. 2007. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat. Immunol. 8:1086-94
132. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. 2004. Retinoic acid imprints guthoming specificity on T cells. Immunity 21:527-38
133. Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ. 2007. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204:1765-74
134. + Tcell effector responses via retinoic acid receptorα. Immunity 34:435-47
135. + T cell-mediated immunity. J. Exp. Med. 208:1767-75
136. DePaolo RW, Abadie V, Tang F, Fehlner-Peach H, Hall JA, et al. 2011. Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature 471:220-24
137. Ahern PP, SchieringC, Buonocore S, McGeachyMJ, Cua DJ, et al. 2010. Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity 33(2):279-88
138. Kaufman DR, De Calisto J, Simmons NL, Cruz AN, Villablanca EJ, et al. 2011. Vitamin A deficiency impairs vaccine-elicited gastrointestinal immunity. J. Immunol. 187:1877-83
139. Spahn TW, Weiner HL, Rennert PD, Lugering N, Fontana A, et al. 2002. Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches. Eur. J. Immunol. 32:1109-13
140. + regulatory T cells in the lamina propria. Immunity 34:237-46
141. Powell JD, Delgoffe GM. 2010. The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. Immunity 33:301-11
142. GaoW, Lu Y, El Essawy B, Oukka M, KuchrooVK, StromTB. 2007. Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatoryTcells. Am. J. Transplant. 7:1722-32
143. + regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR. J. Leukoc. Biol. 83:1230-39
144. Delgoffe GM, Kole TP, Zheng Y, Zarek PE, Matthews KL, et al. 2009. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30:832-44
145. + regulatory T cells. Eur. J. Immunol. 41:1242-48
146. Sauer S, Bruno L, Hertweck A, Finlay D, Leleu M, et al. 2008. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. USA 105:7797-802
147. Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, et al. 2011. Control of TH17/Treg balance by hypoxiainducible factor 1. Cell 146:772-84
148. Shi LZ, Wang R, Huang G, Vogel P, Neale G, et al. 2011. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208(7):1367-76
149. RoncaroloMG, Battaglia M. 2007. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat. Rev. Immunol. 7:585-98
150. Riley JL, June CH, Blazar BR. 2009. Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity 30:656-65
151. Edinger M, Hoffmann P. 2011. RegulatoryTcells in stem cell transplantation: strategies and first clinical experiences. Curr. Opin. Immunol. 23:679-84
152. - T regulatory cells. Clin. Immunol. 133:22-26
153. Hippen KL, Merkel SC, Schirm DK, Sieben CM, Sumstad D, et al. 2011. Massive ex vivo expansion of human natural regulatory T cells (Tregs) with minimal loss of in vivo functional activity. Sci. Transl. Med. 3:83ra41
154. Hippen KL, Riley JL, June CH, Blazar BR. 2011. Clinical perspectives for regulatory T cells in transplantation tolerance. Semin. Immunol. 23:462-68
155. + T cells expressing the FoxP3 transcription factor. Immunity 30:899-911
156. + regulatory T cells. Blood 105:4743-48
157. + T regulatory cells. Haematologica 96:1357-65
158. Hippen KL, Merkel SC, Schirm DK, Nelson C, Tennis NC, et al. 2011. Generation and largescale expansion of human inducible regulatory T cells that suppress graft-versus-host disease. Am. J. Transplant. 11:1148-57
159. + regulatory T cells. Nat. Rev. Immunol. 11:119-30
160. Hori S. 2011. Regulatory T cell plasticity: beyond the controversies. Trends Immunol. 32:295-300
161. Bailey-Bucktrout SL, Bluestone JA. 2011. RegulatoryTcells: stability revisited. Trends Immunol. 32:301-6
162. Floess S, Freyer J, Siewert C, Baron U, Olek S, et al. 2007. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5:e38
163. Polansky JK, Kretschmer K, Freyer J, Floess S, Garbe A, et al. 2008. DNA methylation controls Foxp3 gene expression. Eur. J. Immunol. 38:1654-63